These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Major hyperaldosteronisms secondary to unilateral nephropathy and surgically curable]. Mornex R; Perrin J; Bryon PA; Servonnat P; Gliere R; Bomel J; Fauriel N Sem Hop; 1972 Jan; 48(4):253-66. PubMed ID: 4338346 [No Abstract] [Full Text] [Related]
3. [Secondary hyperaldosteronism with malignant hypertension caused by renal artery thrombosis]. Halvorsen S Tidsskr Nor Laegeforen; 1965 Oct; 85(20):1527-8. PubMed ID: 5884083 [No Abstract] [Full Text] [Related]
4. [Malignant hypertension]. van Ypersele de Strihou C; Loute G Rev Med Suisse Romande; 1974 Nov; 94(11):903-7. PubMed ID: 4155113 [No Abstract] [Full Text] [Related]
5. Renal abnormalities and vascular complications in primary hyperaldosteronism. Evidence on tertiary hyperaldosteronism. Beevers DG; Brown JJ; Ferriss JB; Fraser R; Lever AF; Robertson JI; Tree M Q J Med; 1976 Jul; 45(179):401-10. PubMed ID: 948542 [TBL] [Abstract][Full Text] [Related]
6. [Kidney artery stenosis, renal hypertension and secondary hyperaldosteronism in an 8-year-old boy. (Stunted growth through potassium deficiency)]. Stefan H; Helge H; Merker HJ; Bachmann D Helv Paediatr Acta; 1968 Oct; 23(5):509-24. PubMed ID: 5719053 [No Abstract] [Full Text] [Related]
7. [On a case of malignant hypertension caused by unilateral renal disease with hyperaldosteronism and salt-losing nephritis. Metabolic and ultrastructural findings]. Emanuelli G; Verzetti G; Sirigu F; Busilacchi M; Perpignano G Minerva Med; 1966 May; 57(37):1647-56. PubMed ID: 5949262 [No Abstract] [Full Text] [Related]
8. [Determination of plasmatic renin in renal hypertension (renovascular or parenchymatous). Effects of vascular reconstruction, of nephrectomy and of renal grafting]. Verniory A; Cuykens JJ; Lotteau B; Toussaint C J Urol Nephrol (Paris); 1967; 73(4):276-85. PubMed ID: 4862133 [No Abstract] [Full Text] [Related]
10. The atrophic kidney: its role in hypertension. Gifford RW; McCormack LJ; Poutasse EF Mayo Clin Proc; 1965 Nov; 40(11):834-52. PubMed ID: 5831726 [No Abstract] [Full Text] [Related]
11. [The surgical treatment of hypertension]. Trede M Wien Med Wochenschr; 1970 Nov; 120(46):799-806. PubMed ID: 4934589 [No Abstract] [Full Text] [Related]
12. [What is the importance of renin determination for the clinician?]. Meyer P Mars Med; 1971; 108(11):751-3. PubMed ID: 5158027 [No Abstract] [Full Text] [Related]
13. [Anatomoclinical aspects of malignant hypertension]. Horváth E; Szivós J; Izsák M; Siara E; Tuka P Med Interna (Bucur); 1965 Aug; 17(8):951-8. PubMed ID: 5865248 [No Abstract] [Full Text] [Related]
14. [Plasmatic concentration of renin in human arterial hypertension]. Bianchi G; Campolo L; Riva D; Vegeto A Minerva Nefrol; 1966; 13(4):119-22. PubMed ID: 5995532 [No Abstract] [Full Text] [Related]
15. [Juxtaglomerular hyperplasia, secondary hyperaldosteronism and hypopotassemia in a case of renovascular hypertension caused by extrinsic compression of the renal artery]. Selli M; Romanelli R; Cella PL; Salvetti A; Arrigoni P Folia Endocrinol; 1965 Aug; 18(4):345-56. PubMed ID: 5898911 [No Abstract] [Full Text] [Related]
16. [Nephrovascular hypertension in children]. Dolara A; Manetti A; Vergassola R; Magi L; Moggi P Minerva Pediatr; 1974 Apr; 26(12):619-21. PubMed ID: 4456196 [No Abstract] [Full Text] [Related]